44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Molecular Cancer

Sign up for email alert when new content gets added: Sign up

Michelle Chen*
University of California San Diego School of Medicine, San Diego, Canada, Email: michelleschen@ucla.edu
*Correspondence: Michelle Chen, University of California San Diego School of Medicine, San Diego, Canada, Email: michelleschen@ucla.edu

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@pulsus.com


Chemotherapy (frequently abbreviated to chemo and now and again CTX or CTx) is a sort of cancer treatment that uses one or extra anti-cancer drugs (chemotherapeutic sellers) as part of a standardized chemotherapy routine [1]. Chemotherapy can be given with a healing motive (which nearly always includes combinations of medicine), or it may purpose to extend lifestyles or to lessen symptoms (palliative chemotherapy). Chemotherapy is one of the essential categories of the medical area especially dedicated to pharmacotherapy for most cancers that is called clinical oncology. The time period chemotherapy has come to connote non-particular utilization of intracellular poisons to inhibit mitosis (mobile department) or result in DNA damage that is why inhibition of DNA repair can augment chemotherapy [2]. The connotation of the word chemotherapy excludes extra selective dealers that block extracellular alerts (sign transduction). The developments of treatments with precise molecular or genetic objectives, which inhibit growth-promoting alerts from traditional endocrine hormones in (in most cases estrogens for breast cancer) and androgens for prostate cancer at the moment, are referred to as hormonal therapies.[3-5]


Google Scholar citation report
Citations : 6

Journal of Molecular Cancer received 6 citations as per Google Scholar report

Journal of Molecular Cancer peer review process verified at publons